PE20080362A1 - Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 - Google Patents
Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1Info
- Publication number
- PE20080362A1 PE20080362A1 PE2007000491A PE2007000491A PE20080362A1 PE 20080362 A1 PE20080362 A1 PE 20080362A1 PE 2007000491 A PE2007000491 A PE 2007000491A PE 2007000491 A PE2007000491 A PE 2007000491A PE 20080362 A1 PE20080362 A1 PE 20080362A1
- Authority
- PE
- Peru
- Prior art keywords
- hydroxiesteroid
- cyclohexylpirazole
- lactam
- inhibitors
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE CICLOHEXILPIRAZOL-LACTAMA DE FORMULA (I), EN DONDE R1 Y R2 SON INDEPENDIENTEMENTE H, HALOGENO, -O-CH3, ENTRE OTROS; R3 ES H O HALOGENO; R4 ES H, HALOGENO, CIANO, ALCOXI(C1-C6), 1-(R8)-1H-PIRAZOL-4-IL, PIRIMIDIN-5-IL, 4-(R5)-FENIL R6-SUSTITUIDO, MORFOLIN-4-IL, 4-(R8)-PIPERIDIN-1-IL, ENTRE OTROS. SON SELECCIONADOS: (3R)-3-[3,5-DICLORO-4'-FLUORO[1,1'-BIFENIL]-4-IL)METIL]-1-[(5S)-4,5,6,7-TETRAHIDRO-1H-INDAZOL-5-IL)-2-PIRROLIDINONA, (3R)-3-(3,5-DICLORO-4'-FLUORO-BIFENIL-4-ILMETIL)-1-(4,5,6,7-TETRAHIDRO-1H-INDAZOL-4-IL)-PIRROLIDIN-2-ONA; ENTRE OTROS. TAMBIEN SE REFIERE A COMPUESTOS INTERMEDIOS, UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DE LA 11-ß-HIDROXIESTEROIDE DESHIDROEGNASA TIPO 1 (11-ß-HSD1) POR LO QUE SON UTILES PARA EL TRATAMIENTO DE DIABETES, HIPERGLICEMIA, OBESIDAD, HIPERTENSION, HIPERGLICEMIA, SIDROME METABOLICO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74532006P | 2006-04-21 | 2006-04-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080362A1 true PE20080362A1 (es) | 2008-04-25 |
Family
ID=38595048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000491A PE20080362A1 (es) | 2006-04-21 | 2007-04-20 | Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 |
Country Status (30)
Country | Link |
---|---|
US (1) | US7981918B2 (es) |
EP (1) | EP2029579B1 (es) |
JP (1) | JP5161869B2 (es) |
KR (1) | KR101055576B1 (es) |
CN (1) | CN101426783B (es) |
AR (1) | AR060618A1 (es) |
AU (1) | AU2007240550B2 (es) |
BR (1) | BRPI0710229A2 (es) |
CA (1) | CA2647677C (es) |
CO (1) | CO6140026A2 (es) |
CR (1) | CR10400A (es) |
DO (1) | DOP2007000078A (es) |
EA (1) | EA015675B1 (es) |
EC (1) | ECSP088839A (es) |
ES (1) | ES2533263T3 (es) |
HK (1) | HK1126493A1 (es) |
IL (1) | IL194835A (es) |
JO (1) | JO3042B1 (es) |
MA (1) | MA30476B1 (es) |
MX (1) | MX2008013484A (es) |
MY (1) | MY148128A (es) |
NO (1) | NO20084403L (es) |
NZ (1) | NZ571175A (es) |
PE (1) | PE20080362A1 (es) |
SV (1) | SV2008003070A (es) |
TN (1) | TNSN08405A1 (es) |
TW (1) | TWI347321B (es) |
UA (1) | UA95798C2 (es) |
WO (1) | WO2007124254A2 (es) |
ZA (1) | ZA200808686B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0710273A2 (pt) | 2006-04-21 | 2011-08-09 | Lilly Co Eli | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, intermediário |
ES2435115T3 (es) * | 2006-04-21 | 2013-12-18 | Eli Lilly And Company | Derivados de bifenilamida-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 |
AU2007244960B2 (en) | 2006-04-24 | 2012-03-01 | Eli Lilly And Company | Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
AU2007244955B2 (en) | 2006-04-24 | 2011-12-08 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
EA016415B1 (ru) | 2006-04-24 | 2012-04-30 | Эли Лилли Энд Компани | Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1 |
EP2021337B1 (en) | 2006-04-25 | 2010-01-13 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
CN101432265B (zh) | 2006-04-25 | 2011-12-14 | 伊莱利利公司 | 11-β-羟类固醇脱氢酶1的抑制剂 |
EP2016071B1 (en) | 2006-04-25 | 2013-07-24 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
US7829582B2 (en) * | 2006-04-28 | 2010-11-09 | Eli Lilly And Company | Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
US8835426B2 (en) | 2007-02-26 | 2014-09-16 | Vitae Pharmaceuticals, Inc. | Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1 |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
AR069207A1 (es) | 2007-11-07 | 2010-01-06 | Vitae Pharmaceuticals Inc | Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1 |
EP2229368A1 (en) | 2007-12-11 | 2010-09-22 | Vitae Pharmaceuticals, Inc. | Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
CN102089300B (zh) | 2008-05-01 | 2014-06-18 | 生命医药公司 | 11β-羟基类固醇脱氢酶1的环状抑制剂 |
CN102105454A (zh) | 2008-07-25 | 2011-06-22 | 贝林格尔.英格海姆国际有限公司 | 合成1型11β-羟基类固醇脱氢酶的抑制剂 |
US8846668B2 (en) | 2008-07-25 | 2014-09-30 | Vitae Pharmaceuticals, Inc. | Inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
RU2539979C2 (ru) | 2008-07-25 | 2015-01-27 | Вайтаи Фармасьютиклз, Инк. | Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1 |
EP2393813B1 (en) * | 2009-02-04 | 2013-07-31 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11 ß-hydroxysteroid dehydrogenase 1 useful for the treatment of diseases related to elevated level of cortisol |
US8637505B2 (en) | 2009-02-04 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8507493B2 (en) | 2009-04-20 | 2013-08-13 | Abbvie Inc. | Amide and amidine derivatives and uses thereof |
US8680093B2 (en) | 2009-04-30 | 2014-03-25 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
US8927539B2 (en) | 2009-06-11 | 2015-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure |
WO2011002910A1 (en) | 2009-07-01 | 2011-01-06 | Vitae Pharmaceuticals, Inc. | Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
JP5750449B2 (ja) | 2009-11-05 | 2015-07-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規キラルリンリガンド |
WO2011068927A2 (en) * | 2009-12-04 | 2011-06-09 | Abbott Laboratories | 11-β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11B-HSD1) INHIBITORS AND USES THEREOF |
WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8648192B2 (en) | 2010-05-26 | 2014-02-11 | Boehringer Ingelheim International Gmbh | 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives |
JP5860042B2 (ja) | 2010-06-16 | 2016-02-16 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | 置換5、6及び7員複素環、そのような化合物を含有する医薬及びそれらの使用 |
WO2011157827A1 (de) | 2010-06-18 | 2011-12-22 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
WO2011161128A1 (en) | 2010-06-25 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
AU2011325286B2 (en) | 2010-11-02 | 2015-04-16 | Boehringer Ingelheim International Gmbh | Pharmaceutical combinations for the treatment of metabolic disorders |
WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US8901114B2 (en) | 2011-03-08 | 2014-12-02 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
WO2013045413A1 (en) | 2011-09-27 | 2013-04-04 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
JP6020459B2 (ja) | 2011-10-18 | 2016-11-02 | アステラス製薬株式会社 | 二環式ヘテロ環化合物 |
AR099936A1 (es) * | 2014-04-04 | 2016-08-31 | Sanofi Sa | Heterociclos condensados sustituidos como moduladores de gpr119 para el tratamiento de la diabetes, obesidad, dislipidemia y trastornos relacionados |
US10858347B2 (en) | 2015-12-31 | 2020-12-08 | Karyopharm Therapeutics Inc. | Multicyclic compounds and uses thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004056744A1 (en) | 2002-12-23 | 2004-07-08 | Janssen Pharmaceutica N.V. | Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
US7687644B2 (en) | 2004-05-07 | 2010-03-30 | Janssen Pharmaceutica Nv | Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
AU2005240784C1 (en) | 2004-05-07 | 2011-12-22 | Janssen Pharmaceutica N.V. | Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
EP1802623A1 (en) | 2004-10-12 | 2007-07-04 | Novo Nordisk A/S | 11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds |
SI1807072T1 (sl) | 2004-10-29 | 2009-06-30 | Lilly Co Eli | Derivati cikloalkil laktamov kot inhibitorji 11-beta-hidroksisteroid dehidrogenaze 1 |
CA2585797C (en) | 2004-11-10 | 2015-01-06 | Incyte Corporation | Lactam compounds and their use as pharmaceuticals |
ES2308602T3 (es) | 2004-12-20 | 2008-12-01 | Eli Lilly And Company | Derivados de cicloalquil lactamas como inhibidores de la 11-beta-hidroxiesteroide deshidrogenasa 1. |
ATE401073T1 (de) | 2004-12-21 | 2008-08-15 | Lilly Co Eli | Cycloalkyl-lactam-derivate als inhibitoren von 11-beta-hydroxysteroiddehydrogenase 1 |
EP1864971A4 (en) | 2005-03-31 | 2010-02-10 | Takeda Pharmaceutical | PROPHYLACTIC / THERAPEUTIC AGENT AGAINST DIABETES |
ES2322727B1 (es) | 2005-07-28 | 2010-04-22 | Universidad Del Pais Vasco | Metodo para cuantificar la union receptor acoplado a proteina g (gpcr)-proteina g mediante el empleo de un array de membranas celulares. |
US7998959B2 (en) | 2006-01-12 | 2011-08-16 | Incyte Corporation | Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
ES2435115T3 (es) | 2006-04-21 | 2013-12-18 | Eli Lilly And Company | Derivados de bifenilamida-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 |
BRPI0710273A2 (pt) * | 2006-04-21 | 2011-08-09 | Lilly Co Eli | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, intermediário |
EA016415B1 (ru) | 2006-04-24 | 2012-04-30 | Эли Лилли Энд Компани | Ингибиторы 11-бета-гидроксистероид-дегидрогеназы типа 1 |
AU2007244955B2 (en) | 2006-04-24 | 2011-12-08 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
AU2007244960B2 (en) | 2006-04-24 | 2012-03-01 | Eli Lilly And Company | Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
EP2021337B1 (en) | 2006-04-25 | 2010-01-13 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
EP2016071B1 (en) | 2006-04-25 | 2013-07-24 | Eli Lilly And Company | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
CN101432265B (zh) | 2006-04-25 | 2011-12-14 | 伊莱利利公司 | 11-β-羟类固醇脱氢酶1的抑制剂 |
US7829582B2 (en) | 2006-04-28 | 2010-11-09 | Eli Lilly And Company | Piperidinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
CL2008001839A1 (es) | 2007-06-21 | 2009-01-16 | Incyte Holdings Corp | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. |
-
2007
- 2007-04-05 CA CA2647677A patent/CA2647677C/en not_active Expired - Fee Related
- 2007-04-05 CN CN2007800142829A patent/CN101426783B/zh not_active Expired - Fee Related
- 2007-04-05 WO PCT/US2007/066069 patent/WO2007124254A2/en active Application Filing
- 2007-04-05 KR KR1020087025618A patent/KR101055576B1/ko not_active IP Right Cessation
- 2007-04-05 JP JP2009506680A patent/JP5161869B2/ja not_active Expired - Fee Related
- 2007-04-05 EA EA200870460A patent/EA015675B1/ru not_active IP Right Cessation
- 2007-04-05 US US12/297,375 patent/US7981918B2/en not_active Expired - Fee Related
- 2007-04-05 EP EP07760191.2A patent/EP2029579B1/en active Active
- 2007-04-05 MY MYPI20084205A patent/MY148128A/en unknown
- 2007-04-05 ES ES07760191.2T patent/ES2533263T3/es active Active
- 2007-04-05 BR BRPI0710229-1A patent/BRPI0710229A2/pt active Search and Examination
- 2007-04-05 UA UAA200812290A patent/UA95798C2/ru unknown
- 2007-04-05 AU AU2007240550A patent/AU2007240550B2/en not_active Ceased
- 2007-04-05 MX MX2008013484A patent/MX2008013484A/es active IP Right Grant
- 2007-04-05 NZ NZ571175A patent/NZ571175A/en not_active IP Right Cessation
- 2007-04-18 JO JOP/2007/0149A patent/JO3042B1/ar active
- 2007-04-19 TW TW096113852A patent/TWI347321B/zh not_active IP Right Cessation
- 2007-04-19 DO DO2007000078A patent/DOP2007000078A/es unknown
- 2007-04-20 AR ARP070101715A patent/AR060618A1/es not_active Application Discontinuation
- 2007-04-20 PE PE2007000491A patent/PE20080362A1/es not_active Application Discontinuation
-
2008
- 2008-10-10 ZA ZA200808686A patent/ZA200808686B/xx unknown
- 2008-10-17 TN TNP2008000405A patent/TNSN08405A1/en unknown
- 2008-10-17 CO CO08110816A patent/CO6140026A2/es unknown
- 2008-10-20 NO NO20084403A patent/NO20084403L/no not_active Application Discontinuation
- 2008-10-21 SV SV2008003070A patent/SV2008003070A/es unknown
- 2008-10-21 EC EC2008008839A patent/ECSP088839A/es unknown
- 2008-10-22 IL IL194835A patent/IL194835A/en not_active IP Right Cessation
- 2008-10-24 CR CR10400A patent/CR10400A/es unknown
- 2008-11-20 MA MA31396A patent/MA30476B1/fr unknown
-
2009
- 2009-06-17 HK HK09105407.7A patent/HK1126493A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20080362A1 (es) | Derivados de ciclohexilpirazol-lactama como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1 | |
PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
PE20050948A1 (es) | Compuestos de carbamoil-amina como inhibidores de la dipeptidil peptidasa iv | |
EA200870489A1 (ru) | Пиперидинилзамещённые пирролидиноны в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы 1 | |
EA200601895A1 (ru) | 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов | |
PE20090952A1 (es) | Compuestos de pirazol moduladores de raf | |
PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
PE20091925A1 (es) | Derivados de indazol sustituidos con fenilo o benzodioxinilo | |
PE20120620A1 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas | |
PE20080952A1 (es) | Amidas azociclicas fungicidas | |
PE20091425A1 (es) | Derivados de aminotiazol | |
NO20083909L (no) | Bisykliske benzimidazolforbindelser, og deres anvendelse som metabotropiske glutamatreseptorforsterkere | |
NO20091626L (no) | MGLUR5-modulatorer | |
GB0510143D0 (en) | Novel compounds A1 | |
NO20065456L (no) | Substituerte morfolinforbindelser for behandling av sykdommer i sentralnervesystemet | |
NO20063501L (no) | Kinolinintermediater av reseptor-Tyrosin-Kinase-inhibitorer og deres syntese | |
MY155626A (en) | Organic compounds. | |
PE20080843A1 (es) | Inhibidores de renina y metodo para su utilizacion | |
PE20060977A1 (es) | Derivados de piperidinilo como bloqueantes de canales de calcio | |
PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
PE20081850A1 (es) | Derivados ciclizados como inhibidores de la eg-5 | |
PE20080364A1 (es) | Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa | |
PE20071161A1 (es) | Derivados de urea sustituidos como moduladores del sarcomero cardiaco | |
IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration | ||
FD | Application declared void or lapsed |